Gene regulatory network inference in the era of single-cell multi-omics
The interplay between chromatin, transcription factors and genes generates complex
regulatory circuits that can be represented as gene regulatory networks (GRNs). The study …
regulatory circuits that can be represented as gene regulatory networks (GRNs). The study …
Towards a comprehensive catalogue of validated and target-linked human enhancers
The human gene catalogue is essentially complete, but we lack an equivalently vetted
inventory of bona fide human enhancers. Hundreds of thousands of candidate enhancers …
inventory of bona fide human enhancers. Hundreds of thousands of candidate enhancers …
[HTML][HTML] tagHi-C reveals 3D chromatin architecture dynamics during mouse hematopoiesis
Spatiotemporal chromatin reorganization during hematopoietic differentiation has not been
comprehensively characterized, mainly because of the large numbers of starting cells …
comprehensively characterized, mainly because of the large numbers of starting cells …
Revisiting 3D chromatin architecture in cancer development and progression
Y Feng, S Pauklin - Nucleic Acids Research, 2020 - academic.oup.com
Cancer development and progression are demarcated by transcriptional dysregulation,
which is largely attributed to aberrant chromatin architecture. Recent transformative …
which is largely attributed to aberrant chromatin architecture. Recent transformative …
The current status and future of PD-L1 in liver cancer
L Hao, S Li, J Deng, N Li, F Yu, Z Jiang… - Frontiers in …, 2023 - frontiersin.org
The application of immunotherapy in tumor, especially immune checkpoint inhibitors (ICIs),
has played an important role in the treatment of advanced unresectable liver cancer …
has played an important role in the treatment of advanced unresectable liver cancer …
The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and Aurora kinases
Despite the development of several Fms-like tyrosine kinase 3 (FLT3) inhibitors that have
improved outcomes in patients with FLT3-mutant acute myeloid leukemia (AML), drug …
improved outcomes in patients with FLT3-mutant acute myeloid leukemia (AML), drug …
Clinical impact of 5ʹMYC or 3ʹMYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas
FISH analysis using MYC break-apart probes is a widely used technique to assess for MYC
rearrangement (MYC-R). Occasionally, FISH results in atypical signal patterns, such as gain …
rearrangement (MYC-R). Occasionally, FISH results in atypical signal patterns, such as gain …
Aberrant activation of RPB1 is critical for cell overgrowth in acute myeloid leukemia
Q Yu, Y Xu, H Zhuang, Z Wu, L Zhang, J Li… - Experimental Cell …, 2019 - Elsevier
Acute myeloid leukemia (AML) is a group of highly aggressive malignancies with a 5-year
overall survival of less than 40%. Cell overgrowth with defective apoptosis is a hallmark of …
overall survival of less than 40%. Cell overgrowth with defective apoptosis is a hallmark of …
Anatomy of a superenhancer.
Interferon regulatory factor-8 (IRF8) is the lineage determining transcription factor for the
type one classical dendritic cell (cDC1) subset, a terminal selector for plasmacytoid dendritic …
type one classical dendritic cell (cDC1) subset, a terminal selector for plasmacytoid dendritic …